Name: Latest research reports of Laurus Labs Ltd. authored by BOB Capital Markets Ltd. and published by - Trendlyne research reports.
Item: Laurus Labs Ltd.
Rating: 5
Author: BOB Capital Markets Ltd.

Laurus Labs Ltd.

NSE: LAURUSLABS | BSE: 540222 | ISIN: INE947Q01028 | Industry: Pharmaceuticals
| Expensive Performer

603.0500 -0.65 (-0.11%)

NSE May 16, 2025 15:31 PM

56.45% Gain from 52W Low

Volume: 1.5M

Laurus Labs Ltd.

29 Jan 2021

603.05

-0.11%

Laurus Labs (BUY): Solid margins despite higher API mix TP raised to Rs 480

Buy: Laurus Labs Ltd.

Target

BOB Capital Markets Ltd.

Laurus Labs reported another solid beat in Q3FY21 fuelled by strong growth in the API and synthesis segments.

Laurus Labs Ltd. is trading above its 200 day SMA of 537.6